E71.4
Disorders of carnitine metabolism
Clinical Classification Guidelines
Excludes Type 1
- Muscle carnitine palmitoyltransferase deficiency (E71.314)
Medical Intelligence & Overview
Disorders of carnitine metabolism, classified under ICD-10 code E71.4, are rare inherited conditions that affect the way the body processes and utilizes carnitine. Carnitine is a vital nutrient responsible for transporting fatty acids into the cells' mitochondria, where they are burned for energy. When these disorders occur, the body's ability to produce or utilize carnitine is impaired, which can lead to issues with energy production, especially in muscles and the heart. Recognizing these conditions early is important for managing symptoms and preventing complications.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents that affect enzymes involved in carnitine synthesis or transport. Secondary causes such as certain medical conditions or medications that interfere with carnitine levels. Dietary deficiencies, although rare, can contribute in some cases, especially in individuals with absorption issues.
Key Symptoms: Muscle weakness and fatigue Exercise intolerance Hypotonia (decreased muscle tone) Cardiac problems such as cardiomyopathy Hypoglycemia (low blood sugar levels) Liver dysfunction Developmental delays, especially in infants and children Elevated levels of certain acids in the blood and urine
Diagnostic & Treatment
Diagnosis Path: Diagnosis of disorders of carnitine metabolism involves multiple steps, including blood tests to measure carnitine levels, genetic testing to identify mutations, and metabolic evaluations to assess the presence of abnormal acids or metabolic products. In some cases, a muscle biopsy may be performed to analyze enzyme activity. Early detection through newborn screening can facilitate timely management of these conditions.
Treatment Protocols: Management of these disorders often includes supplementation with L-carnitine to restore normal levels and improve symptoms. Dietary modifications may also be recommended to optimize energy production. In cases involving cardiac or muscle complications, additional treatments such as medications or supportive therapies are considered. Ongoing monitoring is essential to assess treatment response and prevent potential complications.
Clinical Advice & FAQs
Billing Guidance
Is E71.4 a billable ICD-10 code?
Yes, E71.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.4?
Clinical documentation must specify the nature of Disorders of carnitine metabolism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference